This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to ...

While a new NIH policy introduces higher financial stakes and places compliance responsibility firmly with universities, it ...

Trump order targeting accreditation could shake up the small club of groups that set standards for medical schools and ...

The FDA’s decision to ban dyes and other synthetic substances often rests on the Delaney clause, a 49‑word law from 1958 that ...

In a significant move, the NIH said it would reduce its reliance on animals in federally funded research and instead ...

Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...

For example, care technology company WellSky is careful to make sure it’s “keeping a human in the loop and not developing any ...

Trump's canceled NIH grants and HHS layoffs threaten U.S. biomedical leadership, Collins says, as she calls for funding to be ...

NIH has cancelled its participation in Safe to Sleep, a 30-year campaign to prevent babies from dying in their sleep ...

Only 6.9% of people with drug-resistant infections in eight large, low- and middle-income countries received an appropriate ...

Twenty years after the debates of the George W. Bush era, there appears to be a serious threat that all government human ...

Novartis is buying Regulus for $800 million, picking up the biotech's experimental kidney drug that's based off a ...